← Eichor
Study identifier: NCT07134790 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Maternal Probiotic Intervention to Improve Gut Health - Trial II - Burkina Faso (MPIGH-II)

Condition: Environmental Enteric Dysfunction (EED)  ·  Sponsor: University Ghent

PhasePhase 2
Planned participants144
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

Burden: Environmental Enteric Dysfunction (EED) is an enteropathic condition characterized by altered gut permeability, infiltration of immune cells and changes in villous architecture and cell differentiation. EED is a major reason of malnourishment, poor neurological development, stunting, oral vaccine failure, and infection. It is believed that EED is responsible for 40% of all childhood stunting. Knowledge gap: To date the focus of research on childhood stunting has been on the young child. It is increasingly appreciated, however, that stunting often begins in utero and the focus has shifted to women's health and pregnancy. Results from rural Bangladesh reveal poor gestational weight gain that ultimately leads to intrauterine growth restriction, low birth weight and ultimately stunting and wasting. Another study recently completed in slum settlements of Dhaka, Bangladesh demonstrated a high prevalence of EED among undernourished women. Intestinal histopathology was abnormal in more than 80% of women. We postulate that growth retardation in utero is a consequence of EED in the mother during pregnancy and lactation. This leads to systemic inflammation, which lead to disadvantageous partitioning of nutrients, and reduced nutrient availability. Relevance: This trial will explore the conceptual framework that a probiotic or live biotherapeutic product that can improve the composition of gut microbiota, can also displace enteropathogens and reduce biomarkers of intestinal inf…

This description comes directly from the study's public registry record.

Talk to the study team

Trenton M. Dailey-Chwalibóg, M.P.H., Ph.D  ·  +32 9 264 61 80  ·  trenton.daileychwalibog@ugent.be

Laéticia C. Toé, M.D., M.Sc.  ·  +32 9 264 61 80  ·  laeticiaceline.toe@ugent.be

Always discuss trial participation with your own doctor first.

Locations (1)

Agence de Formation de Recherche et d'Expertise en Santé pour l'AfriqueBobo-Dioulasso, Burkina FasoRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07134790